A SECRET WEAPON FOR PHARMACEUTICAL RESEARCH

Antibody avidity satisfies numerous myeloma In the continuing search for innovative treatments to battle refractory and relapsed cancer, new preclinical function in a number of myeloma reveals that rising binding avidity by targeting two antigens in a single T mobile-participating trispecific antibody boosts anti-tumor exercise and lessens the prob